Impact of Histopathological Factors, Patient History and Therapeutic Variables on Recurrence-free Survival after Ductal Carcinoma in Situ: 8-Year Follow-up and Questionnaire Survey

Por van Mackelenbergh, M. T., Lindner, C. M., Heilmann, T., Alkatout, I., Elessawy, M., Mundhenke, C., Maass, N., Schem, C.
Publicado no Geburtshilfe Frauenheilkd (2016)

Shaping the System – The DRG Evaluation Project of the German Society for Gynaecology and Obstetrics (Deutsche Gesellschaft für Gynäkologie und Geburtshilfe, DGGG)

Por Fiori, W., Renner, S. P., Siam, K., Babapirali, J., Roeder, N., Dausch, E., Hildebrandt, T., Hillemanns, P., Nehmzow, M., Zygmunt, M., Piroth, D., Schem, C., Schwenzer, T., Friese, K., Wallwiener, D., Beckmann, M. W.
Publicado em 2013

Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab – a translational project in the neoadjuvant GeparQuinto trial

Por Witzel, I, Loibl, S, von Minckwitz, G, Eidtmann, H, Fehm, T, Khandan, F, Schmatloch, S, Hauschild, M, Bischoff, J, Fasching, P A, Mau, C, Schem, C, Rack, B, Meinhold-Heerlein, I, Liedtke, C, Karn, T, Huober, J, zu Eulenburg, C, Issa-Nummer, Y, Untch, M, Müller, V
Publicado em 2012